___

• 1. Thiboutot DM. Overview of acne and its treatment. Cutis 2008;81(1 Suppl): 3-7.
• 2. Orfanos CE, Bauer R. Evidence for anti-inflammatory activities of oral synthetic retinoids: experimental findings and clinical experience. Br J Dermatol 1983;109 Suppl 25: 55-60.
• 3. Bérard A, Azoulay L, Koren G, Blais L, Perreault S, Oraichi D. Isotretinoin, pregnancies, abortions and birth defects: a population-based perspective. Brit J Clin Pharmacol 2007;63: 196-205.
• 4. Farrell LN, Strauss JS, Straniere AM. The treatment of severe cystic acne with 13-cis-retinoic acid: evaluation of sebum production andthe clinical response in a multiple-dose trial. J Am Acad Dermatol 1980;3: 602-11.
• 5. Shahidullah M. Isotretinoin therapy in acne vulgaris: A 10-year retrospective study in Singapore. Int J Dermatol 1994;33: 60-3.
• 6. Reynolds CP. Differentiating agents in pediatric malignancies: retinoids in neuroblastoma. Curr Oncol Rep 2000;2: 511-8.
• 7. Palumbo A, Battaglio S, Napoli P, Bruno B, Omedè P, Boccadoro M, Pileri A. Retinoic acid inhibits the growth of human myeloma cells in vitro. Br J Haematol 1995;89: 555-60.
• 8. Norris DA, Osborn R, Robinson W, Tonnesen MG. Isotretinoin produces significant inhibition of monocyte and neutrophil chemotaxis in vivo in patients with cystic acne. J Invest Dermatol 1987;89: 38-43.
• 9. Ozdemir MA, Kose M, Karakukcu M, Ferahbas A, Patiroglu T, Koklu E. Isotretinoin-induced agranulocytosis. Pediatr Dermatol 2007;24: 425-6.
• 10. Waisman M. Agranulocytosis from isotretinoids. J Am Acad Dermatol 1988;18(2 Pt 1): 395-6.
• 11. Friedman SJ. Leucopenia and neutropenia associated with isotretinoin therapy. Arch Dermatol 1987;123: 293-5.